P. K. Julka - Concepedia

Author

P. K. Julka

All India Institute of Medical Sciences

Also Known As

D.O. De Dios, Julka P K, P Julka, P K Julka, P K. Julka, P. Julka, P. K. Julka, P.K. Julka, P.K. Jülka, PK Julka

103

Publications

Citations

H-Index

Concepts

All Affiliations

All India Institute of Medical Sciences DR. B.R.A. Institute Rotary Cancer Hospital All India Institute of Medical Sciences Raipur Jehangir Hospital All India Institute of Medical Sciences Bhopal

About

P. K. Julka is an author at All India Institute of Medical Sciences specializing in medicine, radiation oncology, and radiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	228
2	Health Sciences	6	6	124
3	Engineering	2	2	30
4	Biochemistry	1	1	19
5	Immunology	1	1	33

P. K. Julka

Publications

738

Citations

H-Index

Page 1

	Year	Citations
Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer N. R. Jagannathan, Mayank Kumar, V. Seenu, British Journal of Cancer	2001	279
Feasibility of using MRI alone for 3D Radiation Treatment Planning in Brain Tumors Ramachandran Prabhakar, P. K. Julka, T Ganesh, Japanese Journal of Clinical Oncology	2007	61
Genome‐wide small noncoding <scp>RNA</scp> profiling of pediatric high‐grade gliomas reveals deregulation of several mi<scp>RNA</scp>s, identifies downregulation of sno<scp>RNA</scp> cluster <scp>HBII</scp>‐52 and delineates <scp>H3F3A</scp> and TP53 mutant‐specific mi<scp>RNA</scp>s and sno<scp>RNA</scp>s Prerana Jha, Rahul Agrawal, Pankaj Pathak, International Journal of Cancer	2015	43
A phase II study of sequential neoadjuvant gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in patients with operable breast cancer: prediction of response using molecular profiling P. K. Julka, R. T. Chacko, S. Nag, British Journal of Cancer	2008	43
Can field-in-field technique replace wedge filter in radiotherapy treatment planning: a comparative analysis in various treatment sites Ramachandran Prabhakar, P. K. Julka, G. K. Rath Australasian Physical & Engineering Sciences in Medicine Adaptive RadiotherapyHealth SciencesRadiation TherapyRadiotherapy Treatment PlanningRadiation Therapy Planning	2008	38
A rare case of intradural extramedullary Ewing's sarcoma with skip metastasis in the spine K.P. Haresh, S K Chinikkatti, Ramachandran Prabhakar, Spinal Cord Intradural Extramedullary EwingRare CaseSkip MetastasisSpinal TumorSpinal Oncology	2008	33
Clinical Benefit of INCB7839, a Potent and Selective Inhibitor of ADAM10 and ADAM17, in Combination with Trastuzumab in Metastatic HER2 Positive Breast Cancer Patients. Steven Friedman, Richard Levy, William M. Garrett, Cancer Research Breast OncologyImmunologyPharmacotherapyTumor BiologyHer2 Cleavage	2009	33
Lycopene in treatment of high-grade gliomas: A pilot study Tarun Puri, Shikha Goyal, P. K. Julka, Neurology India Therapeutic BenefitSurgical OncologyOncologic ImagingCarcinoma ProstateHigh-grade Gliomas	2010	29
Diagnostic accuracy of integrated<sup>18</sup>F-FDG PET/CT for restaging patients with malignant germ cell tumours Punit Sharma, Tarun Jain, Girish Kumar Parida, British Journal of Radiology	2014	27
ASSESSMENT OF THE THERAPEUTIC RESPONSE OF HUMAN BREAST CARCINOMA USING IN VIVO VOLUME LOCALIZED PROTON MAGNETIC RESONANCE SPECTROSCOPY N. R. Jagannathan, Mahesh Kumar, P. Raghunathan, Current Science EngineeringMagnetic ResonanceMagnetic Resonance ImagingOncologyBioanalysis	1999	19

Page 1